Literature DB >> 9819064

Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities.

M T Tsuang1, M J Lyons, J M Meyer, T Doyle, S A Eisen, J Goldberg, W True, N Lin, R Toomey, L Eaves.   

Abstract

BACKGROUND: Previous research has demonstrated genetic and environmental influences on abuse of individual substances, but there is less known about how these factors may influence the co-occurrence of abuse of different illicit drugs.
METHODS: We studied 3372 male twin pairs from the Vietnam Era Twin Registry. They were interviewed using the Diagnostic Interview Schedule, Version III, Revised to investigate the extent to which the abuse of different categories of drugs occurs together within an individual, as well as the possibility that genetic and environmental factors are responsible for observed co-occurrence. Co-occurrence was quantified using odds ratios and conditional probabilities. Multivariate biometrical modeling analyses were used to assess genetic and environmental influences on co-occurrence.
RESULTS: Abusing any category of drug was associated with a marked increase in the probability of abusing every other category of drugs. We found evidence for a shared or common vulnerability factor that underlies the abuse of marijuana, sedatives, stimulants, heroin or opiates, and psychedelics. This shared vulnerability is influenced by genetic, family environmental, and nonfamily environmental factors, but not every drug is influenced to the same extent by the shared vulnerability factor. Marijuana, more than other drugs, was influenced by family environmental factors. Each category of drug, except psychedelics, had genetic influences unique to itself (ie, not shared with other drug categories). Heroin had larger genetic influences unique to itself than did any other drug.
CONCLUSION: There are genetically and environmentally determined characteristics that comprise a shared or common vulnerability to abuse a range of illicit drugs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9819064     DOI: 10.1001/archpsyc.55.11.967

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  250 in total

Review 1.  Genetic studies of alcoholism and substance dependence.

Authors:  T Reich; A Hinrichs; R Culverhouse; L Bierut
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

2.  Strategies for characterizing complex phenotypes and environments: general and specific family environmental predictors of young adult tobacco dependence, alcohol use disorder, and co-occurring problems.

Authors:  Jennifer A Bailey; Karl G Hill; Meredith C Meacham; Susan E Young; J David Hawkins
Journal:  Drug Alcohol Depend       Date:  2011-06-02       Impact factor: 4.492

3.  The AVPR1A gene and substance use disorders: association, replication, and functional evidence.

Authors:  Brion S Maher; Vladimir I Vladimirov; Shawn J Latendresse; Dawn L Thiselton; Rebecca McNamee; Moonsu Kang; Tim B Bigdeli; Xiangning Chen; Brien P Riley; John M Hettema; Howard Chilcoat; Christian Heidbreder; Pierandrea Muglia; E Lenn Murrelle; Danielle M Dick; Fazil Aliev; Arpana Agrawal; Howard J Edenberg; John Kramer; John Nurnberger; Jay A Tischfield; Bernie Devlin; Robert E Ferrell; Galina P Kirillova; Ralph E Tarter; Kenneth S Kendler; Michael M Vanyukov
Journal:  Biol Psychiatry       Date:  2011-04-22       Impact factor: 13.382

4.  Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden.

Authors:  G Bart; M Heilig; K S LaForge; L Pollak; S M Leal; J Ott; M J Kreek
Journal:  Mol Psychiatry       Date:  2004-06       Impact factor: 15.992

5.  Relationship of substance abuse to dependence in the U.S. general population.

Authors:  Tulshi D Saha; Thomas Harford; Risë B Goldstein; Bradley T Kerridge; Deborah Hasin
Journal:  J Stud Alcohol Drugs       Date:  2012-05       Impact factor: 2.582

6.  Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes.

Authors:  Richard Sherva; Henry R Kranzler; Yi Yu; Mark W Logue; James Poling; Albert J Arias; Raymond F Anton; David Oslin; Lindsay A Farrer; Joel Gelernter
Journal:  Neuropsychopharmacology       Date:  2010-05-19       Impact factor: 7.853

Review 7.  "Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Oluwatosin O Fatusin; Qing-Rong Liu; Carlo Contoreggi; Chuan-Yun Li; Kari Buck; John Crabbe
Journal:  Biochem Pharmacol       Date:  2007-07-25       Impact factor: 5.858

8.  Familial transmission of derived phenotypes for molecular genetic studies of substance use disorders.

Authors:  Stephen V Faraone; Joel J Adamson; Timothy E Wilens; Michael C Monuteaux; Joseph Biederman
Journal:  Drug Alcohol Depend       Date:  2007-09-04       Impact factor: 4.492

9.  Synaptic Plasticity and Signal Transduction Gene Polymorphisms and Vulnerability to Drug Addictions in Populations of European or African Ancestry.

Authors:  Orna Levran; Einat Peles; Matthew Randesi; Joel Correa da Rosa; Jurg Ott; John Rotrosen; Miriam Adelson; Mary Jeanne Kreek
Journal:  CNS Neurosci Ther       Date:  2015-09-19       Impact factor: 5.243

Review 10.  Symbiotic relationship of pharmacogenetics and drugs of abuse.

Authors:  Joni L Rutter
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.